Inhibitory effects of Japanese apricot (Prunus mume Siebold et Zucc.; Ume) on Helicobacter pylori-related chronic gastritis

European Journal of Clinical Nutrition

Volumn 64, Issue 7, 2010, Pages 714-719

  Enomoto, S ^a   Yanaoka, K ^a   Utsunomiya, H ^a   Niwa, T ^a   Inada, K ^b   Deguchi, H ^a   Ueda, K ^a   Mukoubayashi, C ^a   Inoue, I ^a   Maekita, T ^a   Nakazawa, K ^a   Iguchi, M ^a   Arii, K ^a   Tamai, H ^a   Yoshimura, N ^c   Fujishiro, M ^d   Oka, M ^a   Ichinose, M ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

atrophic gastritis; H. pylori; Japanese apricot; serum pepsinogen; Ume

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODY TITER; APRICOT; ARTICLE; ATROPHIC GASTRITIS; ATROPHY; BACTERIUM EXAMINATION; CHRONIC GASTRITIS; CONTROLLED STUDY; DIETARY INTAKE; DISEASE COURSE; ENDOSCOPIC BIOPSY; FEMALE; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION PREVENTION; INFECTION RATE; INTESTINE METAPLASIA; JAPAN; JAPANESE; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL CHEMOTAXIS; PRUNUS MUME; SERODIAGNOSIS; SEX DIFFERENCE;

ADULT; AGED; ANTIBODIES; CHRONIC DISEASE; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FRUIT; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; NEUTROPHILS; PEPSINOGEN C; PLANT PREPARATIONS; PREVALENCE; PRUNUS; QUESTIONNAIRES; STOMACH;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI; PRUNUS MUME;

EID: 77955012596     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2010.70     Document Type: Article

References (32)

1. Becker S, Dossus L, Kaaks R (2009). Obesity related hyperinsulinae- mia and hyperglycaemia and cancer development. Arch Physiol Biochem 115, 86-96.
2. ChenTS, Chang FY, Lee SD (1997). Serodiagnosis of Helicobacter pylori infection: comparison and correlation between enzyme-linked immunosorbent assay and rapid serological test results. J Clin Microbiol 35, 184-186.
3. Correa P, Houghton J (2007). Carcinogenesis of Helicobacter pylori. Gastroenterol 133, 659-672.
4. Dixon MF, Genta RM, Yardley JH, Correa P (1996). Classification and grading of gastritis. The updated Sydney System. InternationalWorkshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20, 1161-1181.
5. Eaton KA, Krakowka S (1992). Chronic active gastritis due to Helicobacter pylori in immunized gnotobiotic piglets. Gastroenterol 103, 1580-1586.
6. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA et al. (2000). Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404, 398-402.
7. Fujita K, Hasegawa M, Fujita M, Kobayashi I, Ozasa K, Watanabe Y (2002). Anti-Helicobacter pylori effects of Bainiku-ekisu (concentrate of Japanese apricot juice). Nippon Shokakibyo Gakkai Zasshi 99, 379-385.
8. Hashimoto T, Yagami F, Owada M, Sugawara T, Kawamura M (2008). Salt preference according to a questionnaire vs dietary salt intake estimated by a spot urine method in participants at a health check-up center. Intern Med 47, 399-403.
9. Hatakeyama M (2004). Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 4, 688-694. (Pubitemid 39215067)
10. Ichinose M, Miki K, Furihata C, Kageyama T, Niwa H, Oka H et al. (1982). Radioimmunoassay of group II pepsinogen in human serum. Clin Chim Acta 122, 61-69.
11. Kabir S (2009). Effect of Helicobacter pylori eradication on incidence of gastric cancer in human and animal models: underlying biochemical and molecular events. Helicobacter 14, 159-171.
12. Kneller RW, You WC, Chang YS, Liu WD, Zhang L, Zhao L et al. (1992). Cigarette smoking and other risk factors for progression of precancerous stomach lesions. J Natl Cancer Inst 84, 1261-1266.
13. Kobayashi M, Tsubono Y, Sasazuki S, Sasaki S, Tsugane S (2002). Vegetables, fruit and risk of gastric cancer in Japan: a 10-year follow-up of the JPHC Study Cohort I. Int J Cancer 102, 39-44.
14. Loffeld RJ, Werdmuller BF, Kusters JG, Kuipers EJ (2000). IgG antibody titer against Helicobacter pylori correlates with presence of cytotoxin associated gene A-positive H.pylori strains. FEMS Immunol Med Microbiol 28, 139-141.
15. Mardh E, Mardh S, Mardh B, Borch K (2002). Diagnosis of gastritis by means of a combination of serological analyses. Clin Chim Acta 320, 17-27.
16. Miki K, Ichinose M, Shimizu A, Huang SC, Oka H, Furihata C et al. (1987). Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn 22, 133-141.
17. Miyazawa M, Utsunomiya H, Inada K, Yamada T, Okuno Y, Tanaka H et al. (2006). Inhibition of Helicobacter pylori motility by (+)- syringaresinol from unripe Japanese apricot. Biol Pharm Bull 29, 172-173.
18. Nozaki K, Shimizu N, Inada K, Tsukamoto T, Inoue M, Kumagai T et al. (2002). Synergistic promoting effects of Helicobacter pylori infection and high-salt diet on gastric carcinogenesis in Mongolian gerbils. Jpn J Cancer Res 93, 1083-1089.
19. Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H et al. (2004). Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 109, 138-143.
20. Ohta Y, Tsuchihashi T, Ueno M, Kajioka T, Onaka U, Tominaga M et al. (2004). Relationship between the awareness of salt restriction and the actual salt intake in hypertensive patients. Hypertension Res 27, 243-246.
21. Otsuka T (2005). Suppressive effect of fruit-juice concentrate of Prunus mume Sieb. et et Zucc. (Japanese apricot, Ume) on Helicobacter pylori-induced glandular stomach lesion in Mongolian gerbils. Asian Pacific J Cancer Prev 6, 337-341.
22. Plebani M, Basso D, Cassaro M, Brigato L, Scrigner M, Toma A et al. (1996). Helicobacter pylori serology in patients with chronic gastritis. Am J Gastroenterol 91, 954-958.
23. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI (1982). Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterol 83, 204-209.
24. Shikata K, Kiyohara Y, Kubo M, Yonemoto K, Ninomiya T, Shirota T et al. (2006). A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: the Hisayama study. Int J Cancer 119, 196-201.
25. Shimizu N, Inada K, Nakanishi H, Tsukamoto T, Ikehara Y, Kaminishi M et al. (1999). Helicobacter pylori infection enhances glandular stomach carcinogenesis in Mongolian gerbils treated with chemical carcinogens. Carcinogenesis 20, 669-676. (Pubitemid 29151306)
26. Tredaniel J, Boffetta P, Buiatti E, Saracci R, Hirsch A (1997). Tobacco smoking and gastric cancer: review and meta-analysis. Int J Cancer 72, 565-573. (Pubitemid 27356154)
27. Utsunomiya H, Yamakawa T, Kamei J, Kadonosono K, Tanaka S (2005). Anti-hyperglycemic effects of plum in a rat model of obesity and type 2 diabetes, Wistar fatty rat. Biomed Res 26, 193-200.
28. Yamagata H, Kiyohara Y, Nakamura S, Kubo M, Tanizaki Y, Matsumoto T et al. (2005). Impact of fasting plasma glucose levels on gastric cancer incidence in a general Japanese population: the Hisayama study. Diabetes Care 28, 789-794.
29. Yanaoka K, Oka M, Mukoubayashi C, Yoshimura N, Enomoto S, Iguchi M et al. (2008a). Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males. Cancer Epidemiol Biomarkers Prev 17, 838-845.
30. Yanaoka K, Oka M, Yoshimura N, Mukoubayashi C, Enomoto S, Iguchi M et al. (2008b). Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsi- nogen and Helicobacter pylori antibody levels. Int J Cancer 123, 917-926.
31. Yanaoka K, Oka M, Ohata H, Yoshimura N, Deguchi H, Mukoubayashi C et al. (2009). Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels. Int J Cancer 125, 2697-2703.
32. Yu GP, Hsieh CC, Wang LY, Yu SZ, Li XL, Jin TH (1995). Green-tea consumption and risk of stomach cancer: a population-based case-control study in Shanghai, China. Cancer Causes Control 6, 532-538.